Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04578665 · ClinicalTrials.gov registry record · NA
Human-like Robotic Controllers for Enhanced Motor Learning
A NA study of Stroke and Spinal Cord Injuries, sponsored by Shirley Ryan AbilityLab.
- Recruiting
- Registry status
- NA
- Development phase
- 764
- Enrollment target
- 1
- Study location
NCT04578665: Recruiting NA study of Stroke and Spinal Cord Injuries, sponsored by Shirley Ryan AbilityLab.
NCT04578665 is a NA study of Stroke and Spinal Cord Injuries that is actively recruiting participants, run by Shirley Ryan AbilityLab. The registered enrollment target is 764 participants, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04578665, a NA study of Stroke and Spinal Cord Injuries, is actively recruiting participants, sponsored by Shirley Ryan AbilityLab.
- RECRUITING
- Registry status
- NA
- Development phase
- 764 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop a new paradigm to understand how humans physically interact with each other at a single and at multiple joints, with multiple contact points, so as to synthesize robot controllers that can exhibit human-like behavior when interacting with humans (e.g., exoskeleton) or other co-robots. The investigators will develop models for a single joint robot (i.e. at the ankle joint) that can vary its haptic behavioral interactions at variable impedances, and replicate in a multi-joint robot (i.e. at the ankle, knee, and hip joints). The investigators will collect data from healthy participants and clinical populations to create a controller based on our models to implement in the robots. Then, the investigators will test our models via the robots to investigate the mechanisms underlying enhanced motor learning during different human-human haptic interaction behaviors (i.e. collaboration, competition, and cooperation. This study will be carried out in healthy participants, participants post-stroke, and participants with spinal cord injury (SCI).
Conditions Studied
Interventions
- BEHAVIORAL Behavioral Interaction Conditions
- DEVICE Haptic Impedance Level
- BEHAVIORAL Skill Level of Partner
- DEVICE Robot Controller Showcase
Study Locations (1)
Illinois
- Shirley Ryan AbilityLab - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 764 participants |
| Start Date | 2021-07-13 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT04578665 shows while recruiting
NCT04578665 is an interventional study that assigns participants to a tested intervention. The registered 764 participants enrollment target is mid-sized for trials with a published cap, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 4 interventions - of which Behavioral Interaction Conditions is the first listed.
NCT04578665 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04578665 about?
NCT04578665 is a clinical study titled "Human-like Robotic Controllers for Enhanced Motor Learning". The purpose of this study is to develop a new paradigm to understand how humans physically interact with each other at a single and at multiple joints, with multiple contact points, so as to synthesize robot controllers that can exhibit human-like behavior when interacting with humans (e.g., exoskel...
What is the current status of trial NCT04578665?
This trial is currently recruiting. It is a NA study. The enrollment target is 764 participants. The study started on 2021-07-13. Estimated completion is 2025-12.
What conditions does trial NCT04578665 study?
This clinical trial studies the following conditions: Stroke, Spinal Cord Injuries.
What interventions are being tested in trial NCT04578665?
The interventions under investigation include: Behavioral Interaction Conditions (BEHAVIORAL), Haptic Impedance Level (DEVICE), Skill Level of Partner (BEHAVIORAL), Robot Controller Showcase (DEVICE).
Who is sponsoring clinical trial NCT04578665?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04578665 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04578665's enrollment target sits among peer trials
764 41st of 454 higher than 414 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05579366 · 764 participants · Phase 1
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- NCT03789552 · 765 participants · Phase 3
Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina
- NCT07195591 · 766 participants · Phase 3
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- NCT06419374 · 762 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI